Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of an investigational antitumor agent versus erlotinib in cancer (Japan)
jRCT2080221476Phase 3Completed
- Start
- Jun 2011
01
Overview
Phase 3 trial in cancer (2 arms). Started Jun 2011; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080221476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221476.